Phase 2b Trial of Neovacs’ Investigational Lupus Immunotherapy on Track to Conclude in 2018 – Lupus News Today
Lupus News Today |
Phase 2b Trial of Neovacs’ Investigational Lupus Immunotherapy on Track to Conclude in 2018
Lupus News Today A Phase 2b clinical trial assessing Neovacs’ investigational immunotherapy for the treatment of systemic lupus erythematosus (SLE) is on schedule to deliver results by mid-2018, the company recently said. The announcement follows an independent review … |
Medical Xpress |
Stem cells could boost this Maryland baby’s heart and chance for a normal life
Medical Xpress Dr. Sunjay Kaushal, director of pediatric and adult congenital surgery at the University of Maryland and one of the nation’s foremost surgeons for hypoplastic left heart syndrome, said Autumn’s general health beyond the condition and her supportive … |
GuruFocus.com |
CRISPR Makes Another Advance in ALS
GuruFocus.com Could the CRISPR-cas9 gene-editing system be the key to a cure for amyotrophic lateral sclerosis (ALS)? A new paper written by a group of Stanford graduate students and just published in the journal Nature Genetics suggests a very hopeful maybe. Here’s … |
